Ulrike Winkler Jenks

Array ( [id] => 7636737 [patent_doc_number] => 06379918 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Composition, formulae, devices and methods for control of specificity and inclusivity of microorganisms containing closely related antigen epitopes' [patent_app_type] => B1 [patent_app_number] => 09/374560 [patent_app_country] => US [patent_app_date] => 1999-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5424 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379918.pdf [firstpage_image] =>[orig_patent_app_number] => 09374560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4342885 [patent_doc_number] => 06214354 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Method for preventing zoster or alleviating varicella related post-herpetic neuralgia' [patent_app_type] => 1 [patent_app_number] => 9/372535 [patent_app_country] => US [patent_app_date] => 1999-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4895 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214354.pdf [firstpage_image] =>[orig_patent_app_number] => 372535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4262842 [patent_doc_number] => 06258932 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Peptides that block viral infectivity and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 9/370368 [patent_app_country] => US [patent_app_date] => 1999-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 30010 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258932.pdf [firstpage_image] =>[orig_patent_app_number] => 370368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6047525 [patent_doc_number] => 20020168635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'NUCLEIC ACIDS ENCODING PROTEINS INVOLVED IN SENSORY TRANSDUCTION' [patent_app_type] => new [patent_app_number] => 09/361630 [patent_app_country] => US [patent_app_date] => 1999-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22378 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20020168635.pdf [firstpage_image] =>[orig_patent_app_number] => 09361630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1285506 [patent_doc_number] => 06635257 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Particles of HCV envelope proteins: use for vaccination' [patent_app_type] => B1 [patent_app_number] => 09/355040 [patent_app_country] => US [patent_app_date] => 1999-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 39 [patent_no_of_words] => 22359 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635257.pdf [firstpage_image] =>[orig_patent_app_number] => 09355040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4310259 [patent_doc_number] => 06242175 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Methods and means relating to retrotransposon and retroviral integration' [patent_app_type] => 1 [patent_app_number] => 9/341515 [patent_app_country] => US [patent_app_date] => 1999-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 13652 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242175.pdf [firstpage_image] =>[orig_patent_app_number] => 341515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1406445 [patent_doc_number] => 06524591 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Monocyte locomotion inhibitory factor' [patent_app_type] => B1 [patent_app_number] => 09/342956 [patent_app_country] => US [patent_app_date] => 1999-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 8348 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524591.pdf [firstpage_image] =>[orig_patent_app_number] => 09342956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534235 [patent_doc_number] => 06489098 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS' [patent_app_type] => B1 [patent_app_number] => 09/339357 [patent_app_country] => US [patent_app_date] => 1999-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19897 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489098.pdf [firstpage_image] =>[orig_patent_app_number] => 09339357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1515483 [patent_doc_number] => 06420545 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'CD4-independent HIV envelope proteins as vaccines and therapeutics' [patent_app_type] => B1 [patent_app_number] => 09/337387 [patent_app_country] => US [patent_app_date] => 1999-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 33807 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420545.pdf [firstpage_image] =>[orig_patent_app_number] => 09337387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1411366 [patent_doc_number] => 06517842 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Marburg virus vaccines' [patent_app_type] => B1 [patent_app_number] => 09/336910 [patent_app_country] => US [patent_app_date] => 1999-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13596 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/517/06517842.pdf [firstpage_image] =>[orig_patent_app_number] => 09336910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4385274 [patent_doc_number] => 06277971 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein' [patent_app_type] => 1 [patent_app_number] => 9/333521 [patent_app_country] => US [patent_app_date] => 1999-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5924 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277971.pdf [firstpage_image] =>[orig_patent_app_number] => 333521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4349177 [patent_doc_number] => 06291217 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Glutathionylspermidine synthetase and processes for recovery and use thereof' [patent_app_type] => 1 [patent_app_number] => 9/330740 [patent_app_country] => US [patent_app_date] => 1999-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 7525 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291217.pdf [firstpage_image] =>[orig_patent_app_number] => 330740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4275044 [patent_doc_number] => 06323336 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'PhoH homolog' [patent_app_type] => 1 [patent_app_number] => 9/322081 [patent_app_country] => US [patent_app_date] => 1999-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14930 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323336.pdf [firstpage_image] =>[orig_patent_app_number] => 322081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4241393 [patent_doc_number] => 06221366 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Intestinal protozoal vaccines' [patent_app_type] => 1 [patent_app_number] => 9/322166 [patent_app_country] => US [patent_app_date] => 1999-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 10474 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221366.pdf [firstpage_image] =>[orig_patent_app_number] => 322166 [rel_patent_id] =>[rel_patent_doc_number] =>)